Figure 2.

Effect of hepatic ischemia reperfusion (HIR) alone or in combination with intraperitoneal administration of vildagliptin (Vilda) (10 mg/kg for 10 days) on mRNA expressions of Toll-like receptor 4 (TLR4), high-mobility group box-1 (HMGB1), and nuclear factor-kappa B (NF-κB) in the hepatic tissues of experimental rats. All data were expressed as mean ± SD. aSignificant difference from the sham group at p < 0.05. bSignificant difference from the HIR group at p < 0.05.